All stocks Β· HESTERBIO
HB

Hester Biosciences Ltd

HESTERBIO BSE Drug Manufacturers - Specialty & Generic Healthcare

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provide…

ISIN INE782E01017
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides Silvectant, a hydrogen peroxide and silver nitrate solution for disinfection of poultry sheds; Hestbac, a probiotic supplement to control pathogenic bacteria; Hestflora, a combined probiotic and prebiotic formulation that supports gut health and performance; AmmoStop, a probiotic blend for odour control and respiratory comfort in poultry farms. It also offers INACTIVATED H9N2 vaccine for low pathogenic avian influenza; ICEFT RTU, a ceftiofur formulation for uterine and bacterial infections; and Inomilk Gel, an oral calcium supplement, as well as operates diagnostic labs for poultry. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.

Key Metrics

as of Sep 2026
Market Cap2,054 Cr
P/E38.70
Div Yield0.46 %
Book Valueβ‚Ή423.00
52w Highβ‚Ή2,684.00
52w Lowβ‚Ή1,239.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 77.00 100.00 77.00 71.00 84.00 82.00 63.00 84.00 82.00 79.00 67.00 70.00 88.00
Expenses 54.00 66.00 60.00 59.00 61.00 63.00 58.00 65.00 65.00 63.00 57.00 57.00 73.00
Operating Profit 23.00 34.00 18.00 12.00 23.00 19.00 5.00 19.00 18.00 16.00 10.00 13.00 14.00
OPM % 29.00 34.00 23.00 17.00 27.00 23.00 8.00 23.00 21.00 20.00 15.00 19.00 16.00
Other Income 89.00 2.00 2.00 12.00 3.00 -6.00 9.00 3.00 2.00 5.00 2.00 6.00 3.00
Depreciation 7.00 6.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 5.00
Interest 3.00 5.00 2.00 2.00 2.00 6.00 -4.00 6.00 5.00 7.00 2.00 8.00 3.00
Profit before tax 102.00 25.00 14.00 17.00 20.00 4.00 13.00 12.00 11.00 10.00 6.00 7.00 9.00
Tax % 5.00 34.00 31.00 16.00 14.00 59.00 15.00 29.00 29.00 35.00 37.00 40.00 25.00
Net Profit 97.00 17.00 9.00 14.00 17.00 2.00 11.00 8.00 7.00 6.00 4.00 4.00 7.00
EPS in Rs 114.00 18.78 10.31 16.99 19.33 1.52 13.71 9.64 7.45 5.82 4.68 4.81 6.90

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 333.00311.00305.00266.00235.00214.00183.00178.00136.00123.00101.0090.00
Expenses 246.00250.00251.00215.00175.00146.00128.00110.0089.0082.0067.0064.00
Operating Profit 87.0062.0054.0051.0060.0069.0055.0068.0047.0041.0034.0025.00
OPM % 26.0020.0018.0019.0026.0032.0030.0038.0035.0033.0034.0028.00
Other Income 19.008.0015.0020.0014.001.006.007.003.000.001.003.00
Interest 11.0013.0020.009.004.007.007.007.004.004.004.005.00
Depreciation 19.0017.0017.0021.0017.0013.0013.0012.0010.007.006.006.00
Profit before tax 76.0040.0032.0040.0054.0050.0041.0057.0036.0031.0025.0018.00
Tax % 24.0027.0034.0030.0026.0031.0025.0028.0036.0026.0023.0026.00
Net Profit 57.0029.0021.0028.0039.0035.0031.0041.0023.0023.0019.0013.00
EPS in Rs 65.4132.3122.2131.3046.2240.4734.2948.8730.1227.6822.5715.99
Dividend Payout % 17.0022.0027.0026.0022.0025.0019.0023.0033.0019.0018.0019.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 9.009.009.009.009.009.009.009.009.009.009.009.00
Reserves 352.00306.00283.00271.00251.00220.00193.00169.00132.00113.0093.0076.00
Borrowings 195.00213.00244.00274.00228.00105.00121.0090.0069.0066.0059.0055.00
Other Liabilities 123.00126.00126.00116.0074.0078.0065.0032.0035.0025.0025.0020.00
Total Liabilities 678.00653.00662.00670.00562.00411.00387.00299.00244.00213.00186.00160.00
Fixed Assets 411.00233.00240.00259.00237.00133.00143.00145.00110.00102.0065.0060.00
CWIP 9.00183.00171.00149.0082.00109.0074.007.0032.0021.0036.0033.00
Investments 43.0034.0030.0025.0021.000.000.000.000.000.000.000.00
Other Assets 215.00203.00221.00237.00222.00169.00170.00148.00102.0089.0085.0068.00
Total Assets 678.00653.00662.00670.00562.00411.00387.00299.00244.00213.00186.00160.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 64.0065.0048.0024.009.0058.0037.0047.0038.0035.0019.0020.00
Cash from Investing Activity -18.00-20.00-22.00-77.00-117.00-42.00-73.00-21.00-26.00-30.00-13.00-21.00
Cash from Financing Activity -49.00-52.00-26.0042.00112.00-18.0019.003.00-11.002.00-7.007.00
Net Cash Flow -3.00-7.000.00-12.003.00-2.00-17.0028.001.006.00-1.005.00
Free Cash Flow 47.0044.0024.00-54.00-87.0017.00-36.0024.0015.005.005.001.00
CFO/OP % 90.00123.00112.0063.0043.00105.0086.0092.00100.00102.0074.00100.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 105.0086.0094.00109.0086.0084.00116.0067.0087.0079.0095.0072.00
Inventory Days 323.00291.00288.00399.00424.00452.00834.00540.00505.00376.00627.00431.00
Days Payable 110.00122.0098.00141.00101.00204.00261.0093.00100.0084.00109.0068.00
Cash Conversion Cycle 318.00255.00284.00367.00409.00332.00690.00514.00491.00371.00614.00434.00
Working Capital Days 54.0074.00112.0088.00113.00134.00104.00106.0082.0090.00112.0076.00
ROCE % 15.0010.009.009.0014.0018.0016.0026.0020.0019.0019.0015.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73
FIIs 0.31 0.38 0.52 0.53 0.51 0.87 0.59 0.61 0.52 0.43 0.43 0.42
DIIs 0.00 0.00 0.01 0.00 0.02 0.02 0.02 0.00 0.00 0.00 0.00 0.00
Public 45.95 45.88 45.75 45.73 45.73 45.38 45.65 45.66 45.74 45.84 45.83 45.84
No. of Shareholders 11,961 12,373 12,603 12,260 11,810 11,853 11,473 11,538 11,305 12,844 13,450 13,342

Corporate Actions

28 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 14 Jul 2026 14 Jul 2026 β€” 11.00
Dividend 06 Aug 2025 06 Aug 2025 β€” 7.00
Dividend 22 Aug 2024 22 Aug 2024 β€” 6.00
Other 22 Aug 2024 β€” β€” β€” Annual General Meeting
Dividend 13 Sep 2023 β€” β€” 8.00
Dividend 11 Aug 2022 β€” β€” 10.00
Dividend 05 Aug 2021 β€” β€” 10.00
Dividend 27 Aug 2020 β€” β€” 6.60
Dividend 18 Jul 2019 β€” β€” 7.00
Dividend 09 Nov 2018 12 Nov 2018 β€” 2.00
Dividend 30 Aug 2018 31 Aug 2018 β€” 2.00
Dividend 02 Aug 2018 β€” β€” 6.00
Dividend 16 Nov 2017 17 Nov 2017 β€” 4.00
Dividend 20 Jul 2017 β€” β€” 2.30
Dividend 03 Nov 2016 04 Nov 2016 β€” 3.00
Dividend 21 Jul 2016 β€” β€” 1.10
Dividend 17 Mar 2016 18 Mar 2016 β€” 3.00
Dividend 10 Sep 2015 β€” β€” 3.10
Dividend 18 Sep 2014 β€” β€” 2.00
Dividend 07 Aug 2013 β€” β€” 2.00
Bonus 27 Sep 2012 β€” 1:2 β€”
Dividend 27 Aug 2012 28 Aug 2012 β€” 1.00
Dividend 25 Aug 2011 β€” β€” 3.50
Dividend 22 Jul 2010 β€” β€” 3.00
Dividend 13 Aug 2009 β€” β€” 2.50
Dividend 21 Aug 2008 β€” β€” 2.50
Dividend 06 Sep 2007 β€” β€” 2.00
Other 29 May 2006 05 Jun 2006 β€” β€” Right Issue of Equity Shares

Announcements

5 filings